| 1 |
35057094 | Safe and Effective Cynomolgus Monkey GLP-Tox Study with Repetitive Intrathecal Application of a TGFBR2 Targeting LNA-Gapmer Antisense Oligonucleotide as Treatment Candidate for Neurodegenerative Disorders. | 2022 Jan 15 |
1 |
| 2 |
35454784 | Differences in the Expression Patterns of TGFβ Isoforms and Associated Genes in Astrocytic Brain Tumors. | 2022 Apr 8 |
1 |
| 3 |
33823905 | Novel therapies emerging in oncology to target the TGF-β pathway. | 2021 Apr 6 |
1 |
| 4 |
34560077 | TGF-β-induced fibrosis: A review on the underlying mechanism and potential therapeutic strategies. | 2021 Nov 15 |
1 |
| 5 |
32178467 | Antisense Oligonucleotide in LNA-Gapmer Design Targeting TGFBR2-A Key Single Gene Target for Safe and Effective Inhibition of TGFβ Signaling. | 2020 Mar 12 |
1 |
| 6 |
32179111 | Lung-targeted delivery of TGF-β antisense oligonucleotides to treat pulmonary fibrosis. | 2020 Jun 10 |
2 |
| 7 |
32194176 | TGF-β activity restoration and phosphodiesterase 4 inhibition as therapeutic options for inflammatory bowel diseases. | 2020 May |
1 |
| 8 |
32710930 | Clinical development of therapies targeting TGFβ: current knowledge and future perspectives. | 2020 Oct |
1 |
| 9 |
17972023 | Treatment of MCF-7 breast cancer cells employing mono- and bispecific antisense oligonucleotides having binding specificity toward proteins associated with autocrine regulated growth and BCL-2. | 2008 |
2 |
| 10 |
17848743 | Bispecific antisense oligonucleotides having binding sites directed against an autocrine regulated growth pathway and bcl-2 for the treatment of prostate tumors. | 2007 |
2 |
| 11 |
17917084 | Combination chemotherapy employing bispecific antisense oligonucleotides having binding sites directed against an autocrine regulated growth pathway and bcl-2 for the treatment of prostate tumors. | 2007 |
1 |
| 12 |
16870352 | Synthesis of branched antisense oligonucleotides having multiple specificities. Treatment of hormone insensitive prostate cancer. | 2006 |
2 |
| 13 |
17136230 | Bispecific antisense oligonucleotides with multiple binding sites for the treatment of prostate tumors and their applicability to combination therapy. | 2006 Oct |
2 |
| 14 |
12665682 | Inhibition of PC-3 prostate cancer cell growth in vitro using both antisense oligonucleotides and taxol. | 2003 |
2 |
| 15 |
12616956 | Backbone modification alters the efficacy of antisense oligonucleotides directed against mRNA encoding either TGF-alpha or EGFR in the treatment of prostate cancer cell lines. | 2002 Dec |
2 |
| 16 |
11778757 | Treatment of the T98G glioblastoma cell line with antisense oligonucleotides directed toward mRNA encoding transforming growth factor-alpha and the epidermal growth factor receptor. | 2001 |
2 |
| 17 |
11127817 | Simultaneous blockage of different EGF-like growth factors results in efficient growth inhibition of human colon carcinoma xenografts. | 2000 Nov 30 |
1 |
| 18 |
10370022 | Increased expression of transforming growth factor-alpha in infantile hypertrophic pyloric stenosis. | 1999 |
1 |
| 19 |
9466051 | Epidermal growth factor-related peptides as targets for experimental therapy of human colon carcinoma. | 1998 |
1 |
| 20 |
9513046 | Downmodulation of TGF-alpha protein expression with antisense oligonucleotides inhibits proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells. | 1998 Apr 1 |
4 |
| 21 |
9232607 | Enhanced expression of bcl-2 following antisense oligonucleotide mediated growth factor deprivation. | 1997 Mar |
1 |
| 22 |
7593635 | Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression. | 1995 Nov |
1 |
| 23 |
8360485 | IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. | 1993 Sep 1 |
1 |
| 24 |
1457828 | Anti-sense transforming growth factor alpha oligonucleotides inhibit autocrine stimulated proliferation of a colon carcinoma cell line. | 1992 Nov |
5 |
| 25 |
2009597 | Molecular cloning of the complementary DNA encoding for the hamster TGF-alpha mature peptide. | 1991 Mar |
1 |
| 26 |
2072905 | The proliferative and morphologic responses of a colon carcinoma cell line (LIM 1215) require the production of two autocrine factors. | 1991 Aug |
3 |